Food News and Research

RSS

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.

2 Dec 2009

U.N. calls for $7.1b in annual aid request

The 2010 appeal "is the largest ever since the creation of the Consolidated Appeal Process in 1991," PTI/Business Standard writes (Sharma, 12/1). "Last year the appeal sought $7 billion, which was then a record," according to the U.N. News Centre.

2 Dec 2009

Middle-aged women more likely to show signs of obesity

A small study of middle-aged women finds that "guilt-ridden dieters," impulsive eaters and those too busy to focus on food are the most likely to show signs of obesity.

2 Dec 2009

South-South Cooperation conference kicks off in Kenya

The High Level United Nations Conference on South-South Cooperation started Tuesday in Nairobi, Kenya, with officials discussing prospects and challenges of the initiative, Xinhua reports (Ooko, 12/1).

2 Dec 2009

Obesity research may be misrepresented by scientists working on bias topics, says UAB study

A new study by researchers at the University of Alabama at Birmingham (UAB) School of Public Health shows that obesity research may be misrepresented by scientists operating with particular biases on topics related to weight, nutrition and the food industry.

1 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

Op-eds on World AIDS Day: Research, funding, hunger, Uganda

The "National Institutes of Health - perhaps our best hope for funding a cure for AIDS - has been underfunded since 2003," Kate Krauss, director of the AIDS Policy Project, writes in a Philadelphia Inquirer opinion piece.

1 Dec 2009

Sperm genes may have a detrimental effect on longevity, says new study

Researchers in Japan have found that female mice produced by using genetic material from two mothers but no father live significantly longer than mice with the normal mix of maternal and paternal genes. Their findings provide the first evidence that sperm genes may have a detrimental effect on lifespan in mammals.

1 Dec 2009

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

Unemployed who are losing COBRA subsidy face dramatically higher insurance payments

The temporary federal subsidy program that helped thousands of unemployed people cover the costs of their health insurance is coming to a close, but government officials are looking for ways to continue it.

1 Dec 2009

Chinese SFDA approves Tianyin Pharmaceutical's Pediatric Fever and Cough Oral Liquid

Tianyin Pharmaceutical Co., Inc.,, a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liquid in dosage form of 10 ml/tube (SFDA approval number Z20093060) and Antibacterial and Anti-inflammatory Capsules in dosage form of 0.27 gram/capsule (SFDA approval number Z20090855).

1 Dec 2009

Pfizer, Protalix team up to develop and market plant-based enzyme for Gaucher’s disease treatment

Pfizer and Protalix (NYSE-Amex: PLX) today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of Gaucher’s disease.

1 Dec 2009

New form of pathogen becomes a healthcare challenge in Africa

Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.

1 Dec 2009

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems, a molecular diagnostics (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health (NIH).

1 Dec 2009

Genetic Analysis introduces GA-map microarray test for screening of infant gut microbiota

Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map™ microarray test for high throughput screening of infant gut microbiota. At the recent Sackler Colloquium on Microbes and Health in the US, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.

1 Dec 2009

Researchers identify better strategies to control weight in adolescents

Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States.

1 Dec 2009

DFG approves establishment of new CRCs; research topics range from modern prostheses to political reforms to marine bacteria

The DFG has approved the establishment of 17 new Collaborative Research Centres as of 1 January 2010. This decision was made recently by the relevant Grants Committee in Bonn.

1 Dec 2009

FDA issues marketing clearance for the OIS EyeScan portable imaging device

Ophthalmic Imaging Systems, a leading digital imaging and informatics company, today announced that its revolutionary new portable imaging device, the OIS EyeScan, has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).

1 Dec 2009

Refuse to file letter on NDA for Cladribine Tablets issued to EMD Serono

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a refuse to file letter from the US Food and Drug Administration (FDA) on the New Drug Application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing forms of multiple sclerosis (MS).

1 Dec 2009

New research suggests high fat, energy-dense foods may activate genes that make us obese

Those extra helpings of gravy and dessert at the holiday table are even less of a help to your waistline than previously thought. According to a new research report recently appearing online in The FASEB Journal (http://www.fasebj.org), a diet that is high in fat and in sugar actually switches on genes that ultimately cause our bodies to store too much fat.

1 Dec 2009